Comparison of the Complete DNA Sequences of the Oka Varicella Vaccine and Its Parental Virus
- 15 November 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 76 (22) , 11447-11459
- https://doi.org/10.1128/jvi.76.22.11447-11459.2002
Abstract
The DNA sequences of the Oka varicella vaccine virus (V-Oka) and its parental virus (P-Oka) were completed. Comparison of the sequences revealed 42 base substitutions, which led to 20 amino acid conversions and length differences in tandem repeat regions (R1, R3, and R4) and in an origin of DNA replication. Amino acid substitutions existed in open reading frames (ORFs) 6, 9A, 10, 21, 31, 39, 50, 52, 55, 59, 62, and 64. Of these, 15 base substitutions, leading to eight amino acid substitutions, were in the gene 62 region alone. Further DNA sequence analysis showed that these substitutions were specific for V-Oka and were not present in nine clinical isolates. The immediate-early gene 62 product (IE62) of P-Oka had stronger transactivational activity than the mutant IE62 contained in V-Oka in 293 and CV-1 cells. An infectious center assay of a plaque-purified clone (S7-01) from the V-Oka with 8 amino acid substitutions in ORF 62 showed smaller plaque formation and less-efficient virus-spreading activity than did P-Oka in human embryonic lung cells. Another clone (S-13) with only five substitutions in ORF 62 spread slightly faster than S7-01 but not as effectively as P-Oka. Moreover, transient luciferase assay in 293 cells showed that transactivational activities of IE62s of S7-01 and S7-13 were lower than that of P-Oka. Based on these results, it appears that amino acid substitutions in ORF 62 are responsible for virus growth and spreading from infected to uninfected cells. Furthermore, the Oka vaccine virus was completely distinguishable from P-Oka and 54 clinical isolates by seven restriction-enzyme fragment length polymorphisms that detected differences in the DNA sequence.Keywords
This publication has 98 references indexed in Scilit:
- Varicella-Zoster Virus gB and gE Coexpression, but Not gB or gE Alone, Leads to Abundant Fusion and Syncytium Formation Equivalent to Those from gH and gL CoexpressionJournal of Virology, 2001
- Nucleotide Sequences that Distinguish Oka Vaccine from Parental Oka and Other Varicella?Zoster Virus IsolatesThe Journal of Infectious Diseases, 2000
- Variable R1 region in varicella zoster virus in fulminant type of acute retinal necrosis syndromeBritish Journal of Ophthalmology, 2000
- Transmission of varicella-zoster virus from a vaccinee with leukemia, demonstrated by polymerase chain reactionThe Journal of Pediatrics, 1994
- Meningoradiculoneuritis Due to Acyclovir-Resistant Varicella-Zoster Virus in a Patient with AIDSThe Journal of Infectious Diseases, 1993
- Molecular Analysis of the Pyrimidine Deoxyribonucleoside Kinase Gene of Wild-type and Acyclovir-resistant Strains of Varicella-Zoster VirusJournal of General Virology, 1988
- The Complete DNA Sequence of Varicella-Zoster VirusJournal of General Virology, 1986
- Analysis of Varicella-Zoster Virus DNAs of Clinical Isolates by Endonuclease HpaIJournal of General Virology, 1986
- Identification of a Varicella-Zoster Virus Origin of DNA Replication and Its Activation by Herpes Simplex Virus Type 1 Gene ProductsJournal of General Virology, 1986
- LIVE VACCINE USED TO PREVENT THE SPREAD OF VARICELLA IN CHILDREN IN HOSPITALPublished by Elsevier ,1974